Understanding Lipoprotein Kinetics in Type 1 Diabetes

Lipoprotein Kinetics in T1D

Recruiting N/A Interventional Study
Type 1 Diabetes
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 45
Sex
Any
Study type
Interventional
Purpose
Basic Science
Participants needed
30 (estimated)
Sponsor
University of Missouri-Columbia · Other
Who this trial is looking for

This trial is looking for adults with type 1 diabetes and healthy individuals to help researchers understand how type 1 diabetes affects heart health. Participants will provide blood samples for testing lipids and glucose levels.

Are You a Good Fit for This Trial?
Must be taking Insulin

You may be able to join if

  • I am between 18 and 45 years old.
  • I am not pregnant or breastfeeding.
  • I have a body mass index between 18.5 and 30.0.
  • My fasting plasma triglyceride level is less than 150 mg/dL.
  • If I have type 1 diabetes, my HbA1c level is less than 8.0%.
  • I have been using stable insulin for at least 8 weeks.
  • If I am a healthy control, my fasting plasma glucose is less than 100 mg/dL.

You may not be able to join if

  • I exercise more than 1.5 hours per week.
  • I use tobacco products or drink excessive amounts of alcohol.
  • I take dietary supplements or medications that affect lipids.
  • I have hypothyroidism or other disorders affecting lipids.
  • I had a severe hypoglycemic event that required help in the past 6 months.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

The purpose of this research study is to understand how type 1 diabetes (T1D) increases the risk for cardiovascular diseases (heart attack and stroke). To this end, the investigators will compare apolipoprotein and triglyceride kinetics in people wtih T1D and healthy control participants.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age: ≥18 but ≤45 years * premenopausal/eumenorrheic and not pregnant or breastfeeding * non-obese (body mass index ≥18.5\<30.0 kg/m2) * Fasting plasma triglyceride \<150 mg/dL Additional inclusion criteria for control subjects: * Fasting plasma glucose \<100 mg/dL * Plasma g…
Contacts

Amanda Heider

(573) 884-6852

ahmc4@health.missouri.edu

CONTACT

Mittendorfer Lab

MittendorferLab@umsystem.edu

CONTACT